Universe Pharmaceuticals INC (NASDAQ:UPC) Sees Significant Growth in Short Interest

Universe Pharmaceuticals INC (NASDAQ:UPC) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 105,500 shares, an increase of 192.2% from the September 30th total of 36,100 shares. Based on an average daily trading volume, of 479,100 shares, the short-interest ratio is presently 0.2 days. Currently, 44.0% of the company’s stock are short sold. Currently, 44.0% of the company’s stock are short sold. Based on an average daily trading volume, of 479,100 shares, the short-interest ratio is presently 0.2 days.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Universe Pharmaceuticals in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Universe Pharmaceuticals presently has a consensus rating of “Sell”.

Universe Pharmaceuticals Stock Up 0.4%

Shares of NASDAQ:UPC opened at $4.72 on Friday. The company has a 50-day simple moving average of $4.65. Universe Pharmaceuticals has a 52-week low of $2.51 and a 52-week high of $197.20. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.62 and a current ratio of 2.78.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.